ArticleDrug safety2021

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.

Gabriella di Mauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.